Deutsches Institut für Zell- und Gewebeersatz (DIZG) gGmbH is a leading non-profit manufacturer of high-quality human tissue allografts and cell cultures. As one of the largest tissue banks in Europe, DIZG produces and provides more than 85,000 tissue grafts annually to support advanced patient care across Germany, Europe, and international markets. Driven by our dedicated in-house R&D team, we are committed to advancing tissue engineering through the continuous development of innovative, safe, and clinically proven allogeneic solutions.

 Our Mission

To provide patients suffering from severe tissue defects with the best possible chances of recovery through safe, effective, and state-of-the-art allograft solutions.

 Core Competencies & Clinical Portfolios

DIZG provides a broad range of specialized tissue products tailored to key medical and surgical disciplines:

• Dental, Maxillofacial & Cranial Surgery: Premium bone graft materials (including mineralized/demineralized allografts) and structural membranes

• Orthopedics, Traumatology & Sports Medicine: Tendons, ligaments, and structural bone allografts

• Spinal Surgery & Soft Tissue Reconstruction

• Ophthalmology & Burn Medicine / Reconstructive Surgery